IJFAB: International Journal of Feminist Approaches to Bioethics
IJFAB: International Journal of Feminist Approaches to Bioethics is a peer-reviewed academic journal that focuses on the intersection of feminism and bioethics. It is dedicated to exploring how feminist perspectives can inform and transform bioethical issues, policies, and practices.
History[edit | edit source]
The journal was established in 2008 and has since become a leading platform for scholarly discussions on feminist bioethics. It is published biannually and features a wide range of articles, reviews, and commentaries.
Scope[edit | edit source]
IJFAB covers a broad spectrum of topics within the field of bioethics, including but not limited to:
- Reproductive rights
- Healthcare ethics
- Medical ethics
- Genetic engineering
- End-of-life care
- Disability studies
- Global health
Editorial Board[edit | edit source]
The journal is managed by an editorial board composed of experts in both feminist theory and bioethics. The board is responsible for the peer-review process, ensuring the quality and relevance of the published content.
Submission and Review Process[edit | edit source]
IJFAB accepts submissions from scholars, practitioners, and activists. All submitted manuscripts undergo a rigorous peer-review process to maintain high academic standards. The journal encourages interdisciplinary approaches and welcomes contributions from diverse fields such as philosophy, sociology, law, and public health.
Impact and Reception[edit | edit source]
Since its inception, IJFAB has been influential in shaping the discourse around feminist bioethics. It has been cited in numerous academic works and has contributed to policy discussions at both national and international levels.
Access and Availability[edit | edit source]
The journal is available through various academic databases and libraries. It offers both print and online editions, making it accessible to a global audience.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
